Interventions for Portal Hypertension: Splenic Artery Embolization

  • Yashwant Patidar


Splenic artery embolization is an additional way to treat the sequel of portal hypertension like variceal hemorrhage (prevention and treatment), hypersplenism, hepatogenic ascites, and hepatic encephalopathy. Partial splenic embolization (PSE) has been widely used in selected patient for the management of sequels of portal hypertension, where other form of therapy is not useful or feasible because of either comorbid condition or deranged liver functions. Two methods are usually used for partial splenic arterial embolization; selective partial embolization and nonselective partial embolization. Proper selection of patients, intervention technique, aseptic measure, antibiotic coverage, and post-procedure care are key factors of success of PSE.


Partial splenic embolization (PSE) Portal hypertension Variceal hemorrhage Hypersplenism Ascites 


  1. 1.
    Maddison FE. Embolic therapy of hypersplenism. Investig Radiol. 1973;8:280–1.CrossRefGoogle Scholar
  2. 2.
    Kutti J, Weinfeld A, Westin J. The relationship between splenic platelet pool and spleen size. Scand J Haematol. 1972;9:351–4.CrossRefGoogle Scholar
  3. 3.
    Xu RY, Liu B, Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. World J Gastroenterol. 2004;10:1072–4.CrossRefGoogle Scholar
  4. 4.
    Taniai N, Onda M, Tajiri T, Toba M, Yoshida H. Endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE). Hepato-Gastroenterology. 1999;46:2849–53.PubMedGoogle Scholar
  5. 5.
    Chikamori F, Kuniyoshi N, Kawashima T, Shibuya S, Takase Y. Combination treatment of partial splenic embolization, endoscopic embolization and transjugular retrograde obliteration for complicated gastroesophageal varices. Hepato-Gastroenterology. 2004;51:1506–9.PubMedGoogle Scholar
  6. 6.
    Palsson B, Hallen M, Forsberg AM, Alwmark A. Partial splenic embolization: long-term outcome. Langenbeck’s Arch Surg. 2003;387:421–6.CrossRefGoogle Scholar
  7. 7.
    Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Takesue M, Yoshida K, Kuboki M, Yamamoto S. Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci. 2006;51:352–8.CrossRefGoogle Scholar
  8. 8.
    Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the English language literature. J Vasc Interv Radiol. 2007;18:463–81.CrossRefGoogle Scholar
  9. 9.
    Hirai K, Kawazoe Y, Yamashita K, et al. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis. Hepato-Gastroenterology. 1986;33(3):105–8.PubMedGoogle Scholar
  10. 10.
    Murata K, Shiraki K, Takase K, Nakano T, Tameda Y. Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepato-Gastroenterology. 1996;43(11):1212–7.PubMedGoogle Scholar
  11. 11.
    Sakata K, Hirai K, Tanikawa K. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism. Hepato-Gastroenterology. 1996;43(7):309–18.PubMedGoogle Scholar
  12. 12.
    Rios R, Sangro B, Herrero I, Quiroga J, Prieto J. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol. 2005;100(6):1311–6.CrossRefGoogle Scholar
  13. 13.
    Firat A, Boyvat F, Moray G, Aytekin C, Karakayali H, Haberal M. Comparison of two different percutaneous splenic artery interventions in the treatment of hypersplenism: preliminary report. Transplant Proc. 2005;37(2):1094–8. Scholar
  14. 14.
    Madoff DC, Denys A, Wallace MJ, et al. Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics. 2005;25(supplement 1):S191–211.CrossRefGoogle Scholar
  15. 15.
    N’Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17(2):179–84.CrossRefGoogle Scholar
  16. 16.
    Obatake M, Muraji T, Kanegawa K, Satoh S, Nishijima E, Tsugawa C. A new volumetric evaluation of partial splenic embolization for hypersplenism in biliary atresia. J Pediatr Surg. 2001;36(11):1615–6.CrossRefGoogle Scholar
  17. 17.
    Harned RK 2nd, Thompson HR, Kumpe DA, Narkewicz MR, Sokol RJ. Partial splenic embolization in five children with hypersplenism: effects of reduced-volume embolization on efficacy and morbidity. Radiology. 1998;209:803–6.CrossRefGoogle Scholar
  18. 18.
    Piffaretti G, Tozzi M, Lomazzi C, Rivolta N, Riva F, Caronno R, Castelli P. Splenic artery aneurysms: postembolization syndrome and surgical complications. Am J Surg. 2007;193(2):166–70.CrossRefGoogle Scholar
  19. 19.
    Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008 Jun;95(6):744–50.CrossRefGoogle Scholar
  20. 20.
    Feng K, Ma K, Liu Q, Wu Q, Dong J, Bie P. Randomized clinical trial of splenic radiofrequency ablation versus splenectomy for severe hypersplenism. Br J Surg. 2011 Mar;98(3):354–61. Scholar
  21. 21.
    Assal F, El Kassas M, Esmail E, Elbadry AA, Abousaif S, Mahdy R, Elfert A. Microwave ablation in the spleen versus partial splenic artery embolisation: a new technique for hypersplenism in cirrhosis. Arab J Gastroenterol. 2017 Mar;18(1):25–9. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2021

Authors and Affiliations

  • Yashwant Patidar
    • 1
  1. 1.Interventional RadiologyInstitute of Liver and Biliary SciencesNew DelhiIndia

Personalised recommendations